Gabapentinoids and the risk of severe exacerbations in patients with chronic obstructive pulmonary disease

Conclusions: In patients with COPD, gabapentinoid use was associated with severe COPD exacerbation, highlighting the importance of risk-benefit assessment when prescribing them in this population.

Source: European Respiratory Journal - October 27, 2023 Category: Respiratory Medicine Authors: Rahman, A., Dell'Aniello, S., Moodie, E., Durand, M., Coulombe, J., Boivin, J.-F., Ernst, P., Renoux, C. Tags: Epidemiology Source Type: research